Association of depressive disorders accompanied by sleep deprivation and the severity of the clinical profile of alcohol dependence

Author(s):  
Ilya Sergeevich Efremov ◽  
Azat Railevich Asadullin ◽  
Elvina Aslyamovna Akhmetova ◽  
Regina Faritovna Nasyrova

The prevalence of depressive disorders and dyssomnia in patients with alcoholism during the period of 7–30 days of abstinence from alcohol is considered in this article. 255 test subjects were examined, among them there were 198 men and 57 women. The average age was 42,17 ± 7,817 (Median = 42). It was found that dyssomnia and depressive disorders have been widespread in patients with alcohol dependence syndrome and associated with each other. The existence of comorbid depressive disorders of various degree of manifestation or subclinical depression accompanied by sleep disorder is associated with severity of drug withdrawal syndrome and risk of complications of drug withdrawal syndrome by convulsive seizures. It is also possible to classify patients with depressive disorders and insomnia as a group of increased suicidal risk, it demonstrates the necessity of closer medical monitoring of this group of patients.

1989 ◽  
Vol 154 (1) ◽  
pp. 83-85 ◽  
Author(s):  
Christopher S. Thomas ◽  
Mark Spurrell ◽  
Richard D. Hackett ◽  
Brian D. Hore

Fifty patients suffering from the alcohol dependence syndrome were detoxified over a 10-day period using a reducing regime of chlordiazepoxide. Twenty-four had been consuming minor tranquillisers together with alcohol prior to admission. The severity of the withdrawal syndrome was assessed daily but no differences were found between the 26 who had taken alcohol alone and the 24 who had taken a combination of alcohol and drugs. Four from each group had a transient hallucinosis and none had fits.


2020 ◽  
Vol 23 (15) ◽  
Author(s):  
Penubarthi Sravanthi ◽  
Kailash S ◽  
Shabeeba Z ◽  
Sivabackiya C ◽  
Srinivasan ◽  
...  

2021 ◽  
Vol 11 ◽  
pp. 204512532199127
Author(s):  
Adele Framer

Although psychiatric drug withdrawal syndromes have been recognized since the 1950s – recent studies confirm antidepressant withdrawal syndrome incidence upwards of 40% – medical information about how to safely go off the drugs has been lacking. To fill this gap, over the last 25 years, patients have developed a robust Internet-based subculture of peer support for tapering off psychiatric drugs and recovering from withdrawal syndrome. This account from the founder of such an online community covers lessons learned from thousands of patients regarding common experiences with medical providers, identification of adverse drug reactions, risk factors for withdrawal, tapering techniques, withdrawal symptoms, protracted withdrawal syndrome, and strategies to cope with symptoms, in the context of the existing scientific literature.


2014 ◽  
Vol 103 (12) ◽  
pp. e538-e543 ◽  
Author(s):  
A Amigoni ◽  
E Vettore ◽  
V Brugnolaro ◽  
L Brugnaro ◽  
D Gaffo ◽  
...  

Author(s):  
Anagha S. Deshmukh ◽  
Samir Kumar Praharaj ◽  
Shweta Rai ◽  
Asha Kamath ◽  
Dinesh Upadhya

Background: Alcohol dependence is a significant public health problem, contributing to the global health burden. Due to its immense socio-economic burden, various psychosocial, psychological, and pharmacological approaches have attempted to alter the behaviour of the patient misusing or abusing alcohol, but their efficacy is modest at best. Therefore, there is a search for newer treatment approaches, including noninvasive brain stimulation in the management of alcohol dependence. We plan to study the efficacy of Prefrontal Cortex Transcranial direct current stimulation Treatment in Alcohol dependence syndrome (PreCoTTA). Methods: Two hundred twenty-five male patients with alcohol dependence syndrome will be randomized into the three study arms (2 active, left dorsolateral prefrontal cortex and left orbitofrontal cortex, and 1 sham) to receive a total of 14 tDCS sessions (10 continuous and 4 booster sessions). Data will be collected from them at five different time points on clinical, neuropsychological and biochemical parameters. In addition, 225 healthy age and education matched controls will be administered the neuropsychological test battery at baseline for comparison with the patient group. Discussion: The proposed study aims to explore the use of non-invasive brain stimulation; tDCS as a treatment alternative. We also aim to overcome the methodological gaps of limited sample sizes, fewer tDCS intervention sessions, lack of long term follow ups to measure the sustainability of gains and lack comprehensive measures to track changes in functioning and abstinence after tDCS intervention. The main outcomes include clinical (reduction in cue-induced craving, time to first drink and QFI); neuropsychological (risk-taking, impulsivity, and other neuropsychological domains) and biochemical markers (BDNF, leptin and adiponectin). The findings of the study will have translational value as it may help to improve the clinician’s ability to effectively manage craving in patients with alcohol dependence syndrome. Furthermore, we will have a better understanding of the neuropsychological and biochemical effects of non-invasive brain stimulation techniques which are of interest in the comprehensive treatment of addiction disorders. Trial registration: The study has been registered with the Clinical Trials Registry-India (CTRI/2020/09/027582) on September 03rd 2020.


2021 ◽  
Vol 171 (6) ◽  
pp. 686-689
Author(s):  
T. V. Davidova ◽  
◽  
T. I. Nevidimova ◽  
L. A. Vertile ◽  
I. A. Zakharova ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document